Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Linares JF, Amanchy R, Greis K, Diaz-Meco MT, Moscat J. Correction for Linares et al., "Phosphorylation of p62 by cdk1 Controls the Timely Transit of Cells through Mitosis and Tumor Cell Proliferation". Mol Cell Biol. 2017;37(15).

Gandy LM, Gumm J, Fertig B, Thessen A, Kennish MJ, Chavan S, et al. Synthesizer: Expediting synthesis studies from context-free data with information retrieval techniques. PLoS One. 2017;12(4):e0175860.

Cunningham F, Gupta P, Becher G, Magro CM. Necrotizing eosinophilic folliculitis: a new manifestation of the atopic diathesis? Clin Exp Dermatol. 2017;42(1):100-101.

Mesa H, Zhang C, Manivel JC, Ulbright TM. Immunophenotypic comparison of testicular sclerosing Sertoli cell tumors and Sertoli cell tumors not otherwise specified. Hum Pathol. 2017;68:99-102.

Virmani P, Busam K, Myskowski PL, Yang A, Magro C, Horwitz S. Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab. JAAD Case Rep. 2017;3(4):269-272.

Pae J, Cinalli RM, Marzio A, Pagano M, Lehmann R. GCL and CUL3 Control the Switch between Cell Lineages by Mediating Localized Degradation of an RTK. Dev Cell. 2017;42(2):130-142.e7.

Margolskee E, Saab J, Geyer JT, Aledo A, Mathew S. A Novel Variant t(1;22) Translocation - ins(22;1)(q13;p13p31) - in a Child with Acute Megakaryoblastic Leukemia. Am J Case Rep. 2017;18:422-426.

Ross AE, Hughes RM, Glavaris S, Ghabili K, He P, Anders NM, et al. Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy. Oncotarget. 2017;8(61):104182-104192.

Yanagida K, Liu CH, Faraco G, Galvani S, Smith HK, Burg N, et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc Natl Acad Sci U S A. 2017;114(17):4531-4536.

Guerrera F, Renaud S, Tabbo F, Voegeli' A-, Filosso PL, Legrain M, et al. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas. Eur J Cardiothorac Surg. 2017;51(4):680-688.